Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Fresenius Kabi unveils nine-month figures

Fresenius Kabi unveils nine-month figures

4th November 2009

Fresenius Kabi, a firm specialising in infusion therapies and clinical nutrition products, has announced its financial results for the first nine months of the year.

Its sales during the period reached 2.2 million euros (two million pounds), compared to the 1.7 million euros registered for the same timeframe of 2008, representing growth of 31 per cent.

The firm’s employee base was expanded by six per cent, reaching a total of 21,677.

Fresenius Kabi’s operating cash flow more than doubled to 311 million euros, mostly due to a tight working capital management, the firm revealed.

Meanwhile, its parent group Fresenius Kabi AG’s net income reached 136 million euros, compared to 149 million euros during the same period of 2008 – a decrease of nine per cent.

The Fresenius Group, which employs over 129,000 employees worldwide, consists of four segments – Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed.

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.